Cancer-associated miRNAs and their therapeutic potential

[1]  J. Inazawa,et al.  Improving the Efficacy of EGFR Inhibitors by Topical Treatment of Cutaneous Squamous Cell Carcinoma with miR-634 Ointment , 2020, Molecular therapy oncolytics.

[2]  C. Poh,et al.  Development of MicroRNAs as Potential Therapeutics against Cancer , 2020, Journal of oncology.

[3]  J. Inazawa,et al.  miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  K. Kelnar,et al.  Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours , 2020, British Journal of Cancer.

[5]  John Paul Shen,et al.  Combination Topical Chemotherapy for the Treatment of an Invasive Cutaneous Squamous Cell Carcinoma , 2020, Journal of drugs in dermatology : JDD.

[6]  J. Inazawa,et al.  Therapeutic Potential of LNP-Mediated Delivery of miR-634 for Cancer Therapy , 2019, Molecular therapy. Nucleic acids.

[7]  R. Foà,et al.  Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia , 2018, Haematologica.

[8]  A. Jackson,et al.  Cobomarsen, an oligonucleotide inhibitor of miR‐155, co‐ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T‐cell lymphoma , 2018, British journal of haematology.

[9]  Behzad Baradaran,et al.  Treating cancer with microRNA replacement therapy: A literature review , 2018, Journal of cellular physiology.

[10]  Kishwer S Nehal,et al.  Update on Keratinocyte Carcinomas. , 2018, The New England journal of medicine.

[11]  Patricia Greninger,et al.  Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin , 2018, PloS one.

[12]  D. Bartel.  Metazoan MicroRNAs , 2018, Cell.

[13]  J. Inazawa,et al.  miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein , 2018, Scientific Reports.

[14]  Edward S. Kim,et al.  Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single‐arm phase II clinical trial , 2017, Journal of the American Academy of Dermatology.

[15]  D. Bailey,et al.  Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study. , 2017, The Lancet. Oncology.

[16]  S. Sidhu,et al.  Translational applications of microRNAs in cancer, and therapeutic implications , 2017, Non-coding RNA research.

[17]  J. Inazawa,et al.  miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer , 2017, Scientific Reports.

[18]  T. Brummer,et al.  MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT-signaling in dendritic cells after stem cell transplantation , 2017, Leukemia.

[19]  J. Pérez-Losada,et al.  Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma , 2017, The British journal of dermatology.

[20]  A. Moore,et al.  Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer , 2017, Scientific Reports.

[21]  F. Slack,et al.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases , 2017, Nature Reviews Drug Discovery.

[22]  N. Pavlakis,et al.  Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer. , 2016, Epigenomics.

[23]  Y. Ishikawa,et al.  MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment , 2016, Journal of clinical medicine.

[24]  K. Polyak,et al.  Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer. , 2015, Cancer research.

[25]  J. Inazawa,et al.  miR-634 Activates the Mitochondrial Apoptosis Pathway and Enhances Chemotherapy-Induced Cytotoxicity. , 2015, Cancer research.

[26]  R. Gregory,et al.  MicroRNA biogenesis pathways in cancer , 2015, Nature Reviews Cancer.

[27]  B. Kroesen,et al.  Immuno‐miRs: critical regulators of T‐cell development, function and ageing , 2015, Immunology.

[28]  W. Foulkes,et al.  DICER1: mutations, microRNAs and mechanisms , 2014, Nature Reviews Cancer.

[29]  Frank J. Slack,et al.  Aberrant Regulation and Function of MicroRNAs in Cancer , 2014, Current Biology.

[30]  J. Inazawa,et al.  The Impact of miRNA-Based Molecular Diagnostics and Treatment of NRF2-Stabilized Tumors , 2013, Molecular Cancer Research.

[31]  J. Inazawa,et al.  miR-655 Is an EMT-Suppressive MicroRNA Targeting ZEB1 and TGFBR2 , 2013, PloS one.

[32]  S. Miyano,et al.  The Tumor-Suppressive miR-497-195 Cluster Targets Multiple Cell-Cycle Regulators in Hepatocellular Carcinoma , 2013, PloS one.

[33]  J. Inazawa,et al.  Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer. , 2013, Carcinogenesis.

[34]  S. Kasar,et al.  MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders , 2012, Leukemia research and treatment.

[35]  Christopher J. Cheng,et al.  Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma , 2012, Proceedings of the National Academy of Sciences.

[36]  J. Inazawa,et al.  Tumor‐suppressive microRNA silenced by tumor‐specific DNA hypermethylation in cancer cells , 2012, Cancer science.

[37]  M. Chambers,et al.  A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck , 2012, Clinical Cancer Research.

[38]  J. Inazawa,et al.  miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. , 2011, Cancer research.

[39]  J. Inazawa,et al.  The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. , 2011, Cancer research.

[40]  C. Croce,et al.  Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer , 2011, Proceedings of the National Academy of Sciences.

[41]  Yan Zhang,et al.  Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth , 2011, Breast Cancer Research.

[42]  Shinji Tanaka,et al.  miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. , 2010, Carcinogenesis.

[43]  S. Armstrong,et al.  A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 Acute Lymphocytic Leukemia cells , 2010, Cell cycle.

[44]  D. Welch,et al.  Metastamir: the field of metastasis-regulatory microRNA is spreading. , 2009, Cancer research.

[45]  Shusheng Wang,et al.  AngiomiRs--key regulators of angiogenesis. , 2009, Current opinion in genetics & development.

[46]  I. Faraoni,et al.  miR-155 gene: a typical multifunctional microRNA. , 2009, Biochimica et biophysica acta.

[47]  Ryan M. O’Connell,et al.  Inositol phosphatase SHIP1 is a primary target of miR-155 , 2009, Proceedings of the National Academy of Sciences.

[48]  C. Croce,et al.  miR-155: On the Crosstalk Between Inflammation and Cancer , 2009, International reviews of immunology.

[49]  Qiong Shao,et al.  MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.

[50]  F. Slack,et al.  A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. , 2008, Cancer research.

[51]  S. Ropero,et al.  A microRNA DNA methylation signature for human cancer metastasis , 2008, Proceedings of the National Academy of Sciences.

[52]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[53]  J. Inazawa,et al.  Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. , 2008, Cancer research.

[54]  A. Krogh,et al.  Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells* , 2008, Journal of Biological Chemistry.

[55]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[56]  Ladan Fazli,et al.  Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development , 2007, Proceedings of the National Academy of Sciences.

[57]  Ying Feng,et al.  Supplemental Data P53-mediated Activation of Mirna34 Candidate Tumor-suppressor Genes , 2022 .

[58]  V. Tarasov,et al.  Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest , 2007, Cell cycle.

[59]  L. Lim,et al.  A microRNA component of the p53 tumour suppressor network , 2007, Nature.

[60]  Michael A. Beer,et al.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.

[61]  Moshe Oren,et al.  Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. , 2007, Molecular cell.

[62]  David P. Bartel,et al.  Supporting Online Material Materials and Methods Fig. S1 Tables S1 and S2 References Database S1 Disrupting the Pairing between Let-7 and Hmga2 Enhances Oncogenic Transformation , 2022 .

[63]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[64]  C. Croce,et al.  miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[65]  Y. Yatabe,et al.  Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.

[66]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Sultan Gulce-Iz,et al.  Therapeutic microRNAs in human cancer , 2019, Cytotechnology.

[68]  遠藤 寛則.  Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer , 2012 .

[69]  M. Esteller,et al.  DNA methylomes, histone codes and miRNAs: tying it all together. , 2009, The international journal of biochemistry & cell biology.

[70]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2008, Nature.